Colossal Unveils GenoMorph AI Platform for Dodo Genome Editing
Oct 14, 2026
Biotech
DropGenie Raises Seed+ Round to Launch Miniaturized Gene Editing Platform
Jun 23, 2026
DropGenie has closed a Seed+ financing round led by Skeleton Key with participation from Merck Global Health Innovation Fund and CQDM to support the commercial launch of its first gene editing product.
DropGenie has closed its Seed+ financing round to support the commercial launch of its first gene editing product, announced in a press release. The round was led by Skeleton Key, with participation from Merck Global Health Innovation Fund, CQDM, Real Ventures, and Anges Québec.
The funding will be used to scale manufacturing, build commercial operations, and accelerate adoption among customers. DropGenie’s platform enables high throughput, miniaturized gene editing workflows that reduce the number of cells and reagents needed per experiment. This approach lowers costs and shortens editing turnaround time while allowing direct edits on primary patient cells.
The company’s technology has already been validated through an Early Access Program with major pharmaceutical, biotech, and research organizations. DropGenie’s process generates standardized, high quality gene editing data that supports data driven discovery across cell therapy and functional biology.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareMore from Funding
Nov 13 Peter Sarlin's PostScriptum takes majority stake in Finnish AI deployment firm Brillian Nov 13 MISTT raises £5 million to build a space-and-time data layer for AI and autonomous systems Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 12 Inveniam acquires Docugami, the document AI startup of XML pioneer Jean Paoli Nov 12 Huang's exit puts extra pressure on Anthropic's IPO next week, investors tell FortuneFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Genie Health Raises $3 Million for AI Health Platform
Oct 21, 2026
Funding
Zealand Pharma signs AI obesity drug deal worth up to $1.2 billion
Oct 15, 2026
Biotech
GenRobot AI raises $100 million for robot training data platform
Nov 03, 2026
Funding
geniosAI emerges from stealth with $19.1 million led by FactSet, with Zoom and General Catalyst
Nov 10, 2026
Funding
Switchpoint Bio raises $5.3 million for AI epigenomics platform
Nov 11, 2026
Funding
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.